The structure of the Agency for Health Technology Assessment and Tariff System includes the following organisational units:
President of the AOTMiT – Roman Topór-Mądry
Human Resources Department
Director – Krzysztof Bąk
Accounts Department
Director
- Planning, Analysis and Reporting Division
- Accounting Division
Legal Department
Director– Ewa Warmińska-Friberg
President’s Office
Director – Kamila Malinowska
- Analysis and Medical Fund Department
- Council Support Division
- Administrative and Organisational Division
- Public Procurement Division
IT Department
Director – Łukasz Bieńkowski
- Remote Team responsible for Programming and Statistics in Cracow
Health Technology Assessment Department
Director – Joanna Parkitna
- Reimbursement Division
- Pharmaceutical Programmes Division
- Chemotherapy Division
- Health Policy Programme Division
- Strategic Analysis Department
- Remote Team responsible for analytical matters in Szczecin
Healthcare Services Department
Director – Dominik Dziurda
- Healthcare Service Analysis Division
- Healthcare Service Standardisation Division
- Benefits Evaluation Methodology Department
- Strategic Projects Department
- Financial and Cost Analysis Development Department
- Remote Team responsible for analytical matters and methodology for the assessment of health services in Cracow
- Remote Team responsible for analytical matters in Wrocław
- Remote Team responsible for analytical matters in Chełm
Tariff System Department
Director – acting director: Agnieszka Włodarczyk
- Data Acquisition Division
- Statistics and Analysis Division
- Reports, Applications and Analytical Tools Division
Independent Working Position: Internal Audits
Independent Working Position: Press Secretary
Legal documents regulating AOTMiT’s work:
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out .
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]